http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112675183-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
| filingDate | 2021-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112675183-B |
| titleOfInvention | Application of PB in preparation of medicine for preventing or treating PILO-induced epilepsy |
| abstract | The invention belongs to the field of pharmaceutical preparations, and particularly relates to application of balamin B (PB) in preparation of a medicament for preventing or treating Pilocarpine (PILO) induced epilepsy. The first discovery shows that the balaneboside B can obviously prolong the latency of pilocarpine-induced epilepsy, shorten the status time of epilepsy, reduce the epileptic seizure level and slow down the weight loss caused by epilepsy, thereby having good prevention and treatment effects on the PILO-induced epilepsy. Has important clinical application value in the aspect of pilocarpine-induced epilepsy and opens up new medicinal application for the active component of the balaneb B. |
| priorityDate | 2021-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 401.